{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T01:24:57Z","timestamp":1763429097979},"reference-count":19,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2003,3,13]],"date-time":"2003-03-13T00:00:00Z","timestamp":1047513600000},"content-version":"vor","delay-in-days":12,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acad Dermatol Venereol"],"published-print":{"date-parts":[[2003,3]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p><jats:bold>Background<\/jats:bold> Vitiligo is a common, acquired, often familial, melanocytopenic disorder with focal depigmentation of the skin. There are several new treatments, that appear to have higher success rates than previous therapies for the treatment of vitiligo. Among these, the most promising one appears to be narrow\u2010band UV\u2010B therapy.<\/jats:p><jats:p><jats:bold>Objective<\/jats:bold> The aim of this open study is to evaluate the efficacy of the BIOSKIN\u00ae micro\u2010phototherapy in the treatment of vitiligo in 734 patients.<\/jats:p><jats:p><jats:bold>Subjects and methods<\/jats:bold> Seven hundred and thirty\u2010four individuals affected by vitiligo (segmental and non\u2010segmental) were treated for 12\u00a0months with a new device called BIOSKIN\u00ae that can produce a focused beam of narrow band UV\u2010B (microphoto\u2010therapy) on vitiligo patches only. Photographs of the subjects were taken at the beginning of the therapy and every month thereafter for 12\u00a0months. The response to treatment was estimated in two comparable photographs using planimetry. The duration of the clinical study was of 2\u00a0years and 8\u00a0months. At the end of this period 734 patients had received each a mean of 24 sessions of treatment during a period of 12 months.<\/jats:p><jats:p><jats:bold>Results<\/jats:bold> Five hundred and ten subjects (69.48%) of the 734 achieved normal pigmentation on more than 75% of the treated areas. In particular, 112 of these were totally repigmented. One hundred and fifty\u2010five (21.12%) individuals achieved 50\u201375% pigmentation of the treated areas, and 69 (9.40%) showed less than 50% repigmentation. No patients showed acute or chronic relevant adverse effects.<\/jats:p><jats:p><jats:bold>Conclusion<\/jats:bold> BIOSKIN\u00ae UV\u2010B microphototherapy seems highly effective in restoring pigmentation in patients affected by vitiligo. As no side\u2010effects have been observed, this could represent the treatment of choice for vitiligo limited to less than 30% of the skin surface.<\/jats:p>","DOI":"10.1046\/j.1468-3083.2003.00743.x","type":"journal-article","created":{"date-parts":[[2004,12,27]],"date-time":"2004-12-27T04:33:13Z","timestamp":1104121993000},"page":"171-177","source":"Crossref","is-referenced-by-count":33,"title":["Narrow\u2010band UV\u2010B micro\u2010phototherapy: a new treatment for vitiligo"],"prefix":"10.1111","volume":"17","author":[{"given":"G","family":"Menchini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Tsoureli\u2010Nikita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Hercogova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2003,3,13]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1470.1989.tb00265.x"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4362.1988.tb01260.x"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(96)90112-7"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.1996.tb00116.x"},{"key":"e_1_2_5_6_2","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1001\/archderm.1997.03890480045006","article-title":"Treatment of vitiligo with UV\u2010B radiation vs topical psoralen plus UV\u2010A","volume":"113","author":"Westerhof W","year":"1997","journal-title":"Arch Dermatol"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2001.114752"},{"key":"e_1_2_5_8_2","unstructured":"NjooMD WesterhofW BosJD BossuytPM.The development of guidelines for the treatment of vitiligo."},{"issue":"11","key":"e_1_2_5_9_2","first-page":"1022","article-title":"Phototherapy with UV\u2010B in vitiligo","volume":"65","author":"Koster W","year":"1990","journal-title":"Z Hautkr"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2001.04181.x"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-1097.1994.tb05101.x"},{"issue":"2","key":"e_1_2_5_12_2","first-page":"93","article-title":"UV\u2010B and the immune system. A review with special emphasis on T cell\u2010mediated immunity","volume":"21","author":"Goettsch W","year":"1993","journal-title":"Thymus"},{"issue":"3","key":"e_1_2_5_13_2","first-page":"394","article-title":"The effect of ultraviolet B irradiation and urocanic acid isomers on dendritic cell migration","volume":"77","author":"Moodycliffe AM","year":"1992","journal-title":"Immunology"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1080\/10715760000300911"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0076-6879(00)19035-4"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.1999.00565.x"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(00)90133-6"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.134.12.1532"},{"issue":"2","key":"e_1_2_5_19_2","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1468-3083.1999.tb00861.x","article-title":"UV\u2010B radiation microphototherapy. An elective treatment for segmental vitiligo","volume":"113","author":"Lotti TM","year":"1999","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2001.00228.x"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1468-3083.2003.00743.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1468-3083.2003.00743.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T09:58:31Z","timestamp":1697191111000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1468-3083.2003.00743.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,3]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2003,3]]}},"alternative-id":["10.1046\/j.1468-3083.2003.00743.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1468-3083.2003.00743.x","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,3]]}}}